Identification & Testing of Novel Cancer-Restricted Targets & Their TCRS to Develop Safe & Effective T-Cell Treatment

Time: 5:30 pm
day: Day 1 – Track A – Evening


To fully exploit the therapeutic potential of TCR-T cells, we use our platform to:

  • Limit toxicity attributed to recognition of identical or highly similar targets outside cancers
  • Deliver shared intracellular targets that are cancer-selective to treat large cohorts of patients
  • Counteract the immune-suppressive nature of tumour microenvironments